WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2016176620) EXTRACELLULAR MATRIX COMPOSITIONS FOR THE TREATMENT OF CANCER OR IMMUNOLOGICAL DISEASES
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2016/176620    International Application No.:    PCT/US2016/030204
Publication Date: 03.11.2016 International Filing Date: 29.04.2016
IPC:
A61K 35/12 (2015.01), C12N 5/071 (2010.01), A61K 39/395 (2006.01)
Applicants: HISTOGEN, INC. [US/US]; 10655 Sorrento Valley Road San Diego, CA 92121 (US)
Inventors: NAUGHTON, Gail, K.; (US).
ZEIGLER, Frank; (US).
PINNEY, Emmett; (US)
Agent: HAILE, Lisa A.; (US)
Priority Data:
62/155,360 30.04.2015 US
Title (EN) EXTRACELLULAR MATRIX COMPOSITIONS FOR THE TREATMENT OF CANCER OR IMMUNOLOGICAL DISEASES
(FR) COMPOSITION DE MATRICE EXTRACELLULAIRE POUR LE TRAITEMENT DU CANCER OU DES MALADIES IMMUNOLOGIQUES
Abstract: front page image
(EN)The present invention is directed to methods of inhibiting cancer cell growth or proliferation by contacting the cancer cell with an extracellular matrix (ECM) composition. Also provided are methods of delivering a chemotherapeutic agent to a cancer cell by contacting a cancer cell with an extracellular matrix composition containing a chemotherapeutic agent. Also provided are compositions containing ECM and a chemotherapeutic agent.
(FR)La présente invention concerne des procédés permettant d'inhiber la croissance ou la prolifération de cellules cancéreuses en mettant en contact la cellule cancéreuse avec une composition de matrice extracellulaire (MEC). L'invention concerne également des procédés permettant d'administrer un agent chimiothérapeutique à une cellule cancéreuse en mettant en contact la cellule cancéreuse avec une composition de matrice extracellulaire contenant un agent chimiothérapeutique. L'invention concerne par ailleurs des compositions contenant une MEC et un agent chimiothérapeutique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)